EX-21.1 4 lgnd_123121xexhibit211.htm EX-21.1
Exhibit 21.1
LIGAND PHARMACEUTICALS INCORPORATED
LIST OF SUBSIDIARIES

Name |  | Jurisdiction of Incorporation
Ab Initio Biotherapeutics, Inc. |  | Delaware
Allergan Ligand Retinoid Therapeutics, Inc. |  | Delaware
Cita NeuroPharmaceuticals Inc. |  | Canada
Crystal Bioscience, Inc. |  | California
CyDex Pharmaceuticals, Inc. |  | Delaware
Glycomed Incorporated |  | California
Icagen, LLC |  | Delaware
Ligand Biopharmaceuticals Incorporated |  | Delaware
Ligand Holdings UK Limited |  | England and Wales
Ligand JVR, Inc. |  | Delaware
Ligand Pharmaceuticals (Canada) Incorporated |  | Canada
Ligand Pharmaceuticals International, Inc. |  | Delaware
Ligand Pharmaceuticals UK Limited |  | United Kingdom
Ligand UK Development Limited |  | England and Wales
Ligand UK Group Limited |  | England and Wales
Ligand UK Limited |  | England and Wales
Ligand UK Research Limited |  | England and Wales
Metabasis Therapeutics, Inc. |  | Delaware
Neurogen Corporation |  | Delaware
OmniAb, Inc. |  | Delaware
OMT I, Inc. |  | Delaware
OMT II, Inc. |  | Delaware
Pfenex Inc. |  | Delaware
Pharmacopeia, LLC |  | Delaware
Seragen Incorporated |  | Delaware
Seragen Technology, Inc. |  | Delaware
Taurus Biosciences, LLC |  | Delaware
Vernalis Therapeutics Inc. |  | Delaware
xCella Biosciences, Inc. |  | Delaware